ESR1 and cancer: Estrogen receptor (ER), human epidermal growth factor receptor 2 (HER-2), vascular endothelial growth factor (VEGF), breast cancer gene 1, and breast cancer gene 2 were identified as the main targets for the development of new drugs for the treatment of BRCA.